Correction: High-risk neuroblastoma stage 4 (NBS4): multi-target inhibitors for c-Src kinases (Csk) and retinoic acid (RA) signalling pathways

Amgad Gerges; Una Canning

doi:10.37349/eds.2026.1008142

Exploration of Drug Science ›› 2026, Vol. 4 ›› Issue (1) :1008142 DOI: 10.37349/eds.2026.1008142

Correction

research-article

Correction: High-risk neuroblastoma stage 4 (NBS4): multi-target inhibitors for c-Src kinases (Csk) and retinoic acid (RA) signalling pathways

Amgad Gerges ¹^,^*
, Una Canning ²

Author information +

History +

PDF (854KB)

Abstract

Cite this article

Download citation ▾

Amgad Gerges, Una Canning. Correction: High-risk neuroblastoma stage 4 (NBS4): multi-target inhibitors for c-Src kinases (Csk) and retinoic acid (RA) signalling pathways. Exploration of Drug Science, 2026, 4 (1) : 1008142 DOI:10.37349/eds.2026.1008142